HomeEnsemble Orthopedics Inc.Ensemble Orthopedics Announces 35th Implantation Of Minimally Invasive CMC Device To Be Showcased At 2021 ASSH Meeting

Ensemble Orthopedics Announces 35th Implantation Of Minimally Invasive CMC Device To Be Showcased At 2021 ASSH Meeting

Ensemble Orthopedics Inc, a privately held company, today announced the 35th implantation of its interpositional CMC device for the treatment of carpometacarpal (CMC or thumb) osteoarthritis.

The company will showcase the Ensemble CMC™ at booth #526 during the 76th Annual Meeting of the American Society for Surgery of the Hand (ASSH) on September 30-October 2 in San Francisco.

The surgery was performed on September 1, 2021 at Ocala Regional Medical Center in Ocala FL by Dr. Nirav Gupta who stated, “The beauty of the Ensemble CMC™ is its simplicity. By leaving surrounding soft tissue and bony structures intact, the procedure allows for decreased operative time. Most importantly, the patients I have implanted with this device demonstrate reduced pain levels and earlier return to function than other surgical treatment options I have used. This implant allows me to expand my practice to patients with moderate, isolated CMC osteoarthritis of the thumb in which symptoms persist despite non-operative management.”

The FDA-cleared Ensemble CMC™ is the first implant in a full product line of minimally invasive, interpositional joint replacement devices for the hand and wrist. “We are encouraged by the short-term clinical outcomes and the pattern of repeated use amongst our trained surgeons,” said William Ogilvie, Co-founder, President and CEO of Ensemble Orthopedics. “These results support the concept of using minimally invasive techniques for hand arthroplasty that provide patients a quicker return to normal function.”

The Ensemble CMC™ was designed to expand the treatment options for osteoarthritis of the carpometacarpal joint in a broader range of patients. The minimally invasive, simple surgical procedure inserts an implant through a small incision without disrupting the surrounding soft tissue structures that stabilize the joint. The device is manufactured from pyrocarbon, a strong, low-friction, biocompatible material which has been shown to provide an ideal surface for sliding contact with bone and cartilage.

Ensemble Orthopedics, a medical device company based in Austin TX, develops proprietary, interpositional implants designed to employ minimally invasive surgical techniques, thereby retaining stabilizing tendons and ligaments, for the treatment of arthritis in the hand and wrist.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy